Vapotherm, Inc. (VAPO)
USD 2.17
(-0.46%)
USD 2.17
(-0.46%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 22.96 Million USD | -30.36% |
| 2022 | 32.98 Million USD | -9.8% |
| 2021 | 36.56 Million USD | 83.98% |
| 2020 | 19.87 Million USD | 117.5% |
| 2019 | 9.13 Million USD | -33.36% |
| 2018 | 13.71 Million USD | 19.65% |
| 2017 | 11.45 Million USD | 39.66% |
| 2016 | 8.2 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 23.29 Million USD | -3.19% |
| 2024 Q1 | 24.06 Million USD | 4.77% |
| 2023 Q4 | 22.96 Million USD | -0.54% |
| 2023 Q1 | 28.49 Million USD | -13.59% |
| 2023 Q2 | 25.14 Million USD | -11.77% |
| 2023 FY | 22.96 Million USD | -30.36% |
| 2023 Q3 | 23.09 Million USD | -8.16% |
| 2022 Q3 | 36.43 Million USD | -5.04% |
| 2022 Q1 | 38.04 Million USD | 4.06% |
| 2022 Q2 | 38.36 Million USD | 0.84% |
| 2022 Q4 | 32.98 Million USD | -9.48% |
| 2022 FY | 32.98 Million USD | -9.8% |
| 2021 Q3 | 24.73 Million USD | -15.76% |
| 2021 Q4 | 36.56 Million USD | 47.84% |
| 2021 Q2 | 29.35 Million USD | 8.98% |
| 2021 Q1 | 26.93 Million USD | 35.54% |
| 2021 FY | 36.56 Million USD | 83.98% |
| 2020 FY | 19.87 Million USD | 117.5% |
| 2020 Q1 | 9.1 Million USD | -0.37% |
| 2020 Q2 | 18.64 Million USD | 104.78% |
| 2020 Q4 | 19.87 Million USD | -20.6% |
| 2020 Q3 | 25.02 Million USD | 34.27% |
| 2019 Q2 | 11.21 Million USD | -9.67% |
| 2019 Q3 | 10.84 Million USD | -3.34% |
| 2019 Q4 | 9.13 Million USD | -15.74% |
| 2019 FY | 9.13 Million USD | -33.36% |
| 2019 Q1 | 12.42 Million USD | -9.41% |
| 2018 Q2 | 10.65 Million USD | 0.0% |
| 2018 FY | 13.71 Million USD | 19.65% |
| 2018 Q4 | 13.71 Million USD | 9.33% |
| 2018 Q3 | 12.54 Million USD | 17.71% |
| 2018 Q1 | - USD | -100.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 11.45 Million USD | 0.0% |
| 2017 FY | 11.45 Million USD | 39.66% |
| 2016 FY | 8.2 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Abbott Laboratories | 6.57 Billion USD | 99.65% |
| Allurion Technologies Inc. | 6.17 Million USD | -272.193% |
| Artivion, Inc. | 81.97 Million USD | 71.982% |
| Avanos Medical, Inc. | 163.2 Million USD | 85.926% |
| Butterfly Network, Inc. | 75.83 Million USD | 69.714% |
| Butterfly Network, Inc. | 75.83 Million USD | 69.714% |
| Bio-Rad Laboratories, Inc. | 780.51 Million USD | 97.057% |
| Boston Scientific Corporation | 2.48 Billion USD | 99.075% |
| CONMED Corporation | 318.32 Million USD | 92.785% |
| Edwards Lifesciences Corporation | 1.16 Billion USD | 98.034% |
| Paragon 28, Inc. | 98.06 Million USD | 76.578% |
| Glaukos Corporation | 41.98 Million USD | 45.296% |
| Globus Medical, Inc. | 848.13 Million USD | 97.292% |
| Inspire Medical Systems, Inc. | 33.88 Million USD | 32.218% |
| Integer Holdings Corporation | 239.71 Million USD | 90.419% |
| Medtronic plc | 5.21 Billion USD | 99.56% |
| Myomo, Inc. | 1.8 Million USD | -1173.519% |
| Nevro Corp. | 118.67 Million USD | 80.646% |
| Owlet, Inc. | 6.49 Million USD | -253.735% |
| Penumbra, Inc. | 388.02 Million USD | 94.081% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 99.041% |
| Sonendo, Inc. | 11.07 Million USD | -107.405% |
| STERIS plc | 674.53 Million USD | 96.595% |
| Stryker Corporation | 4.84 Billion USD | 99.526% |
| Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 99.037% |